Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) compared with standard chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2017-04, Vol.2017 (4)
Hauptverfasser:	Moraes, Fabio Y, Perry, Luke A, Penny-Dimri, Jahan C, Ramson, Dhruvesh, de Castria, Tiago B, Bowman, Rayleen V, Santos, Fábio N, Fong, Kwun M, Riera, Rachel
Format:	Artikel
Sprache:	eng
Schlagworte:	Medicine General & Introductory Medical Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) compared with standard chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer (NSCLC).
ISSN:	1465-1858 1465-1858 1469-493X
DOI:	10.1002/14651858.CD012644